Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, March 31, 2014

Otsuka Acquires Rights to DacogenA from Eisai

Otsuka Pharmaceutical Co., Ltd.has announced an agreement with Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. to acquire rights to the hematological cancer treatment Dacogen A and to an enzyme inhibitor, E7727.

http://ift.tt/1fG49yz
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts